Adagene and City of Hope Open Phase 1 Cancer Trial
The investigator-initiated study will test ivonescimab and ADG126 in advanced microsatellite stable colorectal cancer, enrolling up to 36 patients.
The investigator-initiated study will test ivonescimab and ADG126 in advanced microsatellite stable colorectal cancer, enrolling up to 36 patients.